Vilkmergės klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 365,956 | 398,788 | 464,729 | 514,294 | 541,443 | 647,377 | 767,387 | 952,661 |
| Profit before tax | - | - | - | - | 29,272 | 93,249 | 106,354 | 203,181 |
| Net profit | 102,812 | 44,468 | 124,365 | 116,482 | 29,272 | 90,914 | 103,730 | 170,344 |
| Equity | 106,931 | 38,587 | 158,833 | 331,409 | 358,146 | 248,341 | 352,071 | 542,149 |
| Liabilities | 15,104 | 15,348 | 27,195 | 34,552 | 31,456 | 47,805 | 46,217 | 87,724 |
| Non-current assets | 15,611 | 21,197 | 12,173 | 42,269 | 36,363 | 25,913 | 22,331 | 16,026 |
| Current assets | 106,424 | 64,915 | 208,563 | 326,195 | 355,764 | 275,585 | 378,616 | 621,062 |
| Total assets | 122,035 | 86,112 | 220,736 | 368,464 | 392,127 | 301,498 | 400,947 | 637,088 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 102,884 | 96,817 | 108,226 |
| Social insurance contributions | - | - | - | - | - | 91,008 | 111,848 | 128,817 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +30.2% | +9.0% | +16.5% | +10.7% | +5.3% | +19.6% | +18.5% | +24.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 84.2% | 51.6% | 56.3% | 31.6% | 7.5% | 30.2% | 25.9% | 26.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 96.1% | 115.2% | 78.3% | 35.1% | 8.2% | 36.6% | 29.5% | 31.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 28.1% | 11.2% | 26.8% | 22.6% | 5.4% | 14.0% | 13.5% | 17.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 5.4% | 14.4% | 13.9% | 21.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.4 | 0.2 | 0.1 | 0.1 | 0.2 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 12,656 | 13,911 | 16,306 | 17,683 | 17,234 | 22,070 | 26,847 | 32,385 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vilkmergės klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-11-18 | 2025-12-07 | 0.43 |
| 2025-10-16 | 2025-11-06 | 0.43 |
| 2025-03-18 | 2025-03-24 | 36.12 |
| 2025-01-02 | 2025-01-09 | 28.34 |
| 2024-12-22 | 2024-12-31 | 28.34 |
| 2024-12-17 | 2024-12-20 | 28.34 |
| 2024-10-16 | 2024-11-11 | 28.34 |
| 2024-09-17 | 2024-09-29 | 12.29 |
| 2024-06-18 | 2024-07-10 | 38.76 |
| 2023-11-16 | 2023-12-11 | 18.58 |
| 2023-10-17 | 2023-11-12 | 41.99 |
| 2023-02-17 | 2023-03-06 | 41.99 |
| 2022-11-17 | 2022-11-18 | 4.27 |
| 2022-04-19 | 2022-05-09 | 2.93 |
| 2022-03-16 | 2022-04-12 | 2.93 |
| 2022-02-17 | 2022-03-06 | 0.56 |
| 2021-12-08 | 2021-12-08 | 0.01 |
Vilkmergės klinika - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vilkmerges klinika, UAB (code 300562095) is a Private Limited Liability Company operating in medical specialists activities. In 2025, the company generated revenue of €952.7K and net profit of €170.3K, with a profit margin of 17.9%. Revenue increased by 24.1% year on year, and growth over the past two years reached 47.2%. Profitability also strengthened, as net profit rose from €90.9K in 2023 to €103.7K in 2024 and €170.3K in 2025. The balance sheet expanded further in 2025, with total assets of €637.1K, equity of €542.1K and liabilities of €87.7K. The equity ratio was 85.1%, debt to equity stood at 0.16, and asset turnover reached 1.50x, indicating efficient use of assets. Returns remained strong, with ROE at 31.4% and ROA at 26.7%. Revenue per employee was €32.9K and profit per employee €5.9K.